Showing all posts written by Jordan Cox
Mr. Cox received his J.D. from the Georgetown University Law Center. At Georgetown, Mr. Cox served on the Georgetown Journal of Law & Public Policy. Before coming to law school, Mr. Cox double-majored in Physics and German Studies at Brigham Young University where he graduated with honors.
As a Fulbright Scholar, Mr. Cox studied the optical properties of crystals using high-powered pulsed laser and x-ray systems.
Mr. Cox worked as a summer associate in 2014 before joining the firm as an associate in 2015. Click here to read full bio
In a recent report, the U.S. Department of Health & Human Services (HHS) Office of the Inspector General (OIG) recommended that the U.S. Food & Drug Administration (FDA) include cybersecurity review as a greater part of the premarket
The U.S. Food and Drug Administration (FDA) recently updated its software Precertification Program. A working program was originally rolled out in April 2018, but the program was updated in response to requested public input. The FDA
A recent survey conducted by ZingBox, a Silicon Valley internet security startup, found that more than 90% of healthcare IT networks have Internet of Things (IoT) devices. The survey further found that more than 70% of IT departments believe
MedPlast, Inc. recently announced that it has completed its acquisition of Vention Medical‘s device manufacturing services arm. The press release states that the acquisition “broadens MedPlast’s manufacturing
The United States is the world’s largest medical device exporter, according to reports accounting for $45 billion of over $140 billion in global exports in 2014. This is not surprising since it also produced the largest share
U.S. Senators Cory Gardner (R-CO) and Joe Donnelly (D-IN) recently introduced the Rare Device Innovation Act and the FDA Regulatory Efficiency Act. The bills, if passed, would streamline the U.S. Food and Drug Administration (FDA)